Displaying articles by keyword ETAR

ISSN 2304-7232

Artificial heart creation: what problems are to be solved?

Attempts to create an artificial heart were highlighted by our journal one year ago. Now we can say that there…

Correction of the recording artifacts and detection of the…

This paper describes a novel approach to the analysis of electrocardiographic data based on the consideration of the repetitive P,…

Anatomy and physiology of the sinoatrial node: modern concepts

Deciding to discuss the above topic is determined due to a number of reasons. Firstly, the currently used ablation techniques…

Comparative study of measured heart cycle phase durations: standard…

The article aims at describing the theoretical principles of cardiometry as a fundamentally new scientific field which enables the accurate…

Identification of non-HLA antibodies in ventricular assist device recipients

Published in No.3 November 2013

Recipients of ventricular assist devices (VADR) have a higher incidence to develop antibodies (Abs) against human leukocyte antigens (HLA). Non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are also implicated in the pathogenesis of acute rejection and allograft vasculopathy. We monitored non-HLA- and HLA-Abs in VADR up to one year after implantation.